ABOUT USdot CONTACTdot LOG IN

Archives for April 2007

CryoCor Raises $5.45 Million in Private Placement

San Diego-based CryoCor has raised $5.45 million in a private placement with a group of accredited investors. The company sold 1,052,423 shares of common stock priced at a closing bid price of $5.14 per share. 
CryoCor’s signature product, the Cryoablation System, treats cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac […]

25 April 2007 | Blog | No Comments

Governor Welcomes VCs to Pennsylvania

The governor of Pennsylvania has launched a new program to help attract venture capital to the state’s emerging companies, including those in the life sciences field. The New PA Venture Capital Program is part of Governor Edward Rendell’s $2.8 billion “Economic Stimulus Plan,” designed to bring new businesses and jobs to the region. Under the new venture […]

24 April 2007 | Blog | No Comments

Iapyx Introduces Catheter Stabilization Devices

Iapyx Medical, a San Diego firm that makes single-use medical devices, today introduced two products for reducing the risk of common hospital-acquired infections.
The Stable-Line Arterial catheter stabilization device is designed to prevent inadvertent movement and dislodgment of arterial lines. Suture securement, the traditional means of arterial line securement, increases patients’ risks of developing catheter-related bloodstream […]

24 April 2007 | Blog | No Comments

Strongest Quarter Ever for Life Sciences Venture Funding

Life sciences venture funding reached an all-time high in the first quarter of 2007, with 36% of total investments going toward the sector. Medical device companies contributed $1.08 billion in 96 deals, which marks a 60% improvement over the last quarter of 2006. Biotechnology was the single largest sector, with $1.5 billion going into 102 deals. ”Biotech […]

24 April 2007 | Blog | No Comments

When’s the Right Time to Hire a PR Pro?

Jim Weinrebe has been doing healthcare PR and marketing for over 20 years. In his current role as senior vice president at Schwartz Communications, Weinrebe works with a variety of medical device, e-health and healthcare IT clients. To name just a few, Boston-based Schwartz has as clients Caliper Life Sciences, iCAD, NeuroMetrix and NxStage Medical. Med Tech […]

24 April 2007 | Blog, Q&A | No Comments

Sights Set on Advancing Treatment for Retinal Disease

A piece from the current issue of The American focuses on three small med tech firms’ efforts to reverse blindness – and the challenges such companies face in garnering funds for their innovative projects. 
Neurotech, from Lincoln, RI, is conducting trials for its Encapsulated Cell Technology (ECT), which the company is using to make implants for treating retinal […]

20 April 2007 | Blog | No Comments

Evera Gets CE Mark Approval for Lip Implant

Evera Medical (formerly Juva Medical), of Foster City, CA, has received CE Mark approval for a saline-filled implant for facial soft tissue augmentation called FulFil. The first product will be a lip implant for permanent reversible enlargement. A cosmetic surgeon in London, the first physician to treat a patient with FulFil after Evera got the okay […]

20 April 2007 | Blog | No Comments

Smart Buys: OSI Systems and Viasys Healthcare

In the May issue of SmartMoney, the magazine picks its top-10 stocks for the next 10 years. To make the first cut, companies had to show a “demonstrable history of sales growth.” Then, SmartMoney editors “sorted through the remaining stocks one by one, looking for common themes that were likely to play out over the […]

20 April 2007 | Blog | No Comments

IntriCon Bolsters Medical Business with Tibbetts Acquisition

IntriCon Corporation, an Arden Hills, MN, company that makes miniature medical and electronics products, has agreed to buy privately held Tibbetts Industries for $4.5 million cash. Focused on four key markets — medical, hearing health, professional audio and communications, and electronics — IntriCon will use the assets from Tibbetts primarily for medical purposes. “Our acquisition […]

20 April 2007 | Blog | No Comments

FDA Okays Cepheid’s Test for MSRA

FDA signed off yesterday on a new test for identifying Methicillin-resistant Staphylococcus aureus (MSRA), the leading cause of hospital-acquired infections. The Xpert MSRA test, made by Sunnyvale, CA-based Cepheid, runs on the company’s GeneXpert System and delivers results in just over one hour.
According to the CDC, more than 2 million infections occur in hospitals annually, and […]

19 April 2007 | Blog | 2 Comments

Navigation

Archives

Meta

Search

Seeking Alpha Certified
Equities Building Research Building Enterprises Building Resources Building blog counter